Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06397729 · ClinicalTrials.gov registry record · NA

Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics

A NA study of Obesity and Cardiovascular Diseases, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06397729: Recruiting NA study of Obesity and Cardiovascular Diseases, sponsored by Washington University School of Medicine.

NCT06397729 is a NA study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06397729, a NA study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This project will conduct a pilot hybrid study that examines the implementation (Aims 1 \& 2) and preliminary effectiveness (Aim 3) of PREVENT, a digital health intervention, among patients with overweight/obesity (N=100) using a clinic-randomized design. The central hypothesis of the study is that PREVENT will be feasible and show improvements in health behavior counseling and the patient experience that will improve patients' motivation to change, and their CVH health behaviors and outcomes.

Primary Outcome

A survey (4-questions) will assess provider's confidence in delivering health behavior counseling and discussing cardiovascular health with patients. Questions are asked on a 5-point Likert scale (range: 4-20) with a higher score indicating greater satisfaction. Change in confidence from baseline to post-study will be compared in intervention clinics versus control clinics.

Interventions

  • BEHAVIORAL Wait-List Control
  • BEHAVIORAL PREVENT Tool

Study Locations (1)

Missouri

  • Washington University in St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-11-01
Est. Completion 2026-07-30
Phase NA

What NCT06397729 shows while recruiting

NCT06397729 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Wait-List Control is the first listed.

NCT06397729 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06397729 about?

NCT06397729 is a clinical study titled "Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics". This project will conduct a pilot hybrid study that examines the implementation (Aims 1 \& 2) and preliminary effectiveness (Aim 3) of PREVENT, a digital health intervention, among patients with overweight/obesity (N=100) using a clinic-randomized design. The central hypothesis of the study is that ...

What is the current status of trial NCT06397729?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-11-01. Estimated completion is 2026-07-30.

What conditions does trial NCT06397729 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases.

What interventions are being tested in trial NCT06397729?

The interventions under investigation include: Wait-List Control (BEHAVIORAL), PREVENT Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT06397729?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06397729 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06397729's enrollment target sits among peer trials

100 478th of 1053 higher than 555 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06397729, the US trial registry maintained by the National Library of Medicine. NCT06397729 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.